SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193805-24-000619
Filing Date
2024-05-09
Accepted
2024-05-09 08:00:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d14125002_05062024.htm SC 13D 203598
2 JOINT FILING AGREEMENT ex991tosc13d14125002_050624.htm EX-99.1 19432
  Complete submission text file 0001193805-24-000619.txt   224796
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85963 | Film No.: 24928665
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12 E. 49TH STREET 40TH FLOOR NEW YORK NY 10017
Business Address 12 E. 49TH STREET 40TH FLOOR NEW YORK NY 10017 2122594370
Whitefort Capital Management, LP (Filed by) CIK: 0001884931 (see all company filings)

IRS No.: 820808818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D